| [1] |
中国医师协会神经外科医师分会，中国神经创伤专家委员会. 中国颅脑创伤颅内压监测专家共识[J]. 中华神经外科杂志, 2011, 27(10): 1073-1074.
|
| [2] |
Klatzo I. Pathophysiological aspects of brain edema[J]. Acta Neuropathol, 1987, 72(3): 236-239.
|
| [3] |
Cook AM, Morgan Jones G, Hawryluk GWJ, et al. Guidelines for the acute treatment of cerebral edema in neurocritical care patients[J]. Neurocrit Care, 2020, 32(3): 647-666.
|
| [4] |
王浩，胡深，冯诣, 等. 贝伐单抗靶向治疗重度脑水肿临床研究及评估[J]. 临床军医杂志, 2016, 44(9): 904-906.
|
| [5] |
Stokum JA, Gerzanich V, Simard JM. Molecular pathophysiology of cerebral edema[J]. J Cereb Blood Flow Metab, 2016, 36(3): 513-538.
|
| [6] |
Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling[J]. Nat Rev Mol Cell Biol, 2016, 17(10): 611-625.
|
| [7] |
Rattner A, Williams J, Nathans J. Roles of HIFs and VEGF in angiogenesis in the retina and brain[J]. J Clin Invest, 2019, 129(9): 3807-3820.
|
| [8] |
Zhuang H, Shi S, Yuan Z, et al. Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues[J]. Mol Cancer, 2019, 18(1): 21.
|
| [9] |
Naikoo NA, Dil-Afroze , Rasool R, et al. Upregulation of vascular endothelial growth factor (VEGF), its role in progression and prognosis of non-small cell lung carcinoma[J]. Cancer Genet, 2017, 216-217: 67-73.
|
| [10] |
Gonzalez J, Kumar AJ, Conrad CA, et al. Effect of bevacizumab on radiation necrosis of the brain[J]. Int J Radiat Oncol Biol Phys, 2007, 67(2): 323-326.
|
| [11] |
Tripathi M, Ahuja CK, Mukherjee KK, et al. The safety and efficacy of bevacizumab for radiosurgery-induced steroid-resistant brain edema; not the last part in the ship of theseus[J]. Neurol India, 2019, 67(5): 1292-1302.
|
| [12] |
Voss M, Wenger KJ, Fokas E, et al. Single-shot bevacizumab for cerebral radiation injury[J]. BMC Neurol, 2021, 21(1): 77.
|
| [13] |
Rahbari NN, Kedrin D, Incio J, et al. Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases[J]. Sci Transl Med, 2016, 8(360): 360ra135.
|
| [14] |
Zhan Q, Miao F, Huang R, et al. Efficacy and safety of bevacizumab combined with chemotherapy in symptomatic brain metastases from lung adenocarcinoma: a retrospective analysis[J]. J Thorac Dis, 2019, 11(11): 4725-4734.
|
| [15] |
赵儒钢，孟祥颖，申戈, 等. 贝伐珠单抗治疗脑转移瘤难治性瘤周水肿的疗效分析?[J]. 临床肿瘤学杂志, 2016, 21(3): 233-237.
|
| [16] |
Halstead MR, Geocadin RG. The medical management of cerebral edema: past, present, and future therapies[J]. Neurotherapeutics, 2019, 16(4): 1133-1148.
|
| [17] |
杨三虎，高红祥，崔立春, 等. 贝伐珠单抗治疗非小细胞肺癌脑转移伴顽固性瘤周水肿的临床分析[J]. 中华肺部疾病杂志(电子版), 2020, 13(5): 676-678.
|